Nuclear proteins and cell death in inherited neuromuscular disease
Neuromuscular Disorders, ISSN: 0960-8966, Vol: 10, Issue: 4, Page: 217-227
2000
- 23Citations
- 17Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations23
- Citation Indexes23
- 23
- CrossRef18
- Captures17
- Readers17
- 17
Review Description
X-linked Emery–Dreifuss muscular dystrophy is caused by mutations in emerin, a novel nuclear membrane protein. Other major inherited neuromuscular diseases have now also been shown to involve proteins which localize and function at least partly in the cell nucleus. These include lamin A/C in autosomal dominant Emery–Dreifuss muscular dystrophy, SMN in spinal muscular atrophy, SIX5 in myotonic dystrophy, calpain3 in type 2A limb-girdle muscular dystrophy, PABP2 in oculopharyngeal dystrophy, androgen receptor in spinal and bulbar muscular atrophy and the ataxins in hereditary ataxias. This review compares the molecular basis for these various disorders and considers the role of cell death, including apoptosis, in their pathogenesis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0960896699001315; http://dx.doi.org/10.1016/s0960-8966(99)00131-5; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034213121&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/10838245; https://linkinghub.elsevier.com/retrieve/pii/S0960896699001315; http://linkinghub.elsevier.com/retrieve/pii/S0960896699001315; http://api.elsevier.com/content/article/PII:S0960896699001315?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0960896699001315?httpAccept=text/plain; http://dx.doi.org/10.1016/s0960-8966%2899%2900131-5; https://dx.doi.org/10.1016/s0960-8966%2899%2900131-5
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know